BeStock  
Stocks › Biotechnology › PRAX

Praxis Precision Medicines PRAX

US equityMarket cap rank #1557Biotechnology
$300.43 −$10.47 (-3.37%)
Market closed · Nov 22, 5:10 am ET · Last extended-hours $300.43 0.00%
Open$310.07
Prev close$310.90
Day range$298.54 – $314.15
Volume806.2K
Market cap$8.40B
P/E (TTM)–
Dividend yield–

Fundamentals

Latest reported quarter: Q3, ended Sep 2026

Revenue$0.00
Operating profit-$106.91M-36.4% YoY
Net profit-$94.23M-27.5% YoY
Diluted EPS-$3.23+3.9% YoY
Free cash flow-$82.52M-26.8% YoY
Operating cash flow-$81.74M

Revenue, last 8 quarters

$7.5MDec '24$0.0Mar '25$0.0Jun '25$0.0Sep '25$0.0Dec '25$0.0Mar '26$0.0Jun '26$0.0Sep '26

Net profit, last 8 quarters

$-58.7MDec '24$-69.3MMar '25$-71.1MJun '25$-73.9MSep '25$-88.9MDec '25$-92.6MMar '26$-83.7MJun '26$-94.2MSep '26

Diluted EPS by quarter

-2.94Dec '24-3.29Mar '25-3.31Jun '25-3.36Sep '25-3.50Dec '25-3.20Mar '26-2.87Jun '26-3.23Sep '26

Free cash flow by quarter

$-56.1MDec '24$-53.0MMar '25$-54.7MJun '25$-65.1MSep '25$-76.3MDec '25$-86.2MMar '26$-78.6MJun '26$-82.5MSep '26

Annual revenue

$0.0FY20$0.0FY21$0.0FY22$2.4MFY23$8.6MFY24$0.0FY25

Profitability & balance sheet

Return on equity-44.8%
Return on assets-42.1%
Return on invested capital-44.8%
Current ratio14.53
Liabilities / assets4.0%
Cash & investments$745.32M
Net cash (debt)$745.32M

Income statement

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Total Operating Revenue $0.00 $0.00 $0.00 $0.00 $0.00
Operating Expense $106.91M $96.90M $105.86M $326.20M $97.04M
Selling and Admin Expenses $42.71M $27.49M $27.87M $59.08M $19.54M
-General & Admin Expense $42.71M $27.49M $27.87M $59.08M $19.54M
Research & Development $64.21M $69.42M $77.99M $267.12M $77.51M
Operating Profit -$106.91M -$96.90M -$105.86M -$326.20M -$97.04M
Other Income (Expense) $12.68M $13.18M $13.30M $22.93M $8.13M
Other Non-Operating Income (Expenses) $12.68M $13.18M $13.30M $22.93M $8.13M
Pretax Profit -$94.23M -$83.72M -$92.56M -$303.27M -$88.91M
Net Profit -$94.23M -$83.72M -$92.56M -$303.27M -$88.91M
Profit from Continuing Operations -$94.23M -$83.72M -$92.56M -$303.27M -$88.91M
Net Income to Parent Company -$94.23M -$83.72M -$92.56M -$303.27M -$88.91M
Net Income to Common Stockholders -$94.23M -$83.72M -$92.56M -$303.27M -$88.91M
Basic EPS -$3.23 -$2.87 -$3.20 -$13.48 -$3.50
Diluted EPS -$3.23 -$2.87 -$3.20 -$13.48 -$3.50
Total Revenue as Reported – – – $0.00 $0.00

Balance sheet

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Total Assets $1.31B $1.39B $1.46B $937.91M $937.91M
Total Current Assets $762.80M $771.90M $797.77M $610.91M $610.91M
Cash and Cash Equivalents & Short-Term Investments $745.32M $758.55M $786.87M $599.33M $599.33M
-Cash and Cash Equivalents $361.85M $474.76M $536.33M $357.33M $357.33M
-Short Term Investments $383.47M $283.79M $250.53M $242.00M $242.00M
Other Current Assets $17.48M $13.35M $10.91M $11.58M $11.58M
Total Non-Current Assets $549.27M $618.20M $662.43M $327.00M $327.00M
Net PPE $2.58M $1.49M $1.49M $239,000.00 $239,000.00
-Gross PPE $2.58M $1.49M $1.49M $1.74M $1.74M
Investments and Advances $540.70M $615.29M $660.94M $326.76M $326.76M
-Available for Sale Securities $540.70M $615.29M $660.94M $326.76M $326.76M
Other Non-Current Assets $6.00M $643,000.00 – – –
Total Liabilities $52.50M $49.06M $50.24M $59.77M $59.77M
Total Current Liabilities $52.50M $49.06M $50.24M $59.77M $59.77M
Payables $15.02M $23.39M $31.16M $24.63M $24.63M
-Accounts Payable $15.02M $23.39M $31.16M $24.63M $24.63M
Current Accrued Expenses $29.51M $20.88M $14.66M $16.32M $16.32M
Short-Term Debt and Capital Lease Obligation $732,000.00 $1.09M $1.44M $110,000.00 $110,000.00
-Current Capital Lease Obligation $732,000.00 $1.09M $1.44M $110,000.00 $110,000.00
Total Non-Current Liabilities $0.00 $0.00 $0.00 $0.00 $0.00
Total Equity $1.26B $1.34B $1.41B $878.14M $878.14M
Stockholders' Equity $1.26B $1.34B $1.41B $878.14M $878.14M
Capital Stock $15,000.00 $15,000.00 $15,000.00 $15,000.00 $15,000.00
-Common Stock $15,000.00 $15,000.00 $15,000.00 $15,000.00 $15,000.00
-Preferred Stock $0.00 $0.00 $0.00 $0.00 $0.00
Additional Paid-In Capital $2.68B $2.66B $2.64B $2.02B $2.02B
Retained Earnings -$1.41B -$1.32B -$1.23B -$1.14B -$1.14B
Gains/Losses Not Affecting Retained Earnings -$5.73M -$2.67M -$1.59M $563,000.00 $563,000.00
Goodwill and Other Intangible Assets – $773,000.00 – – –
-Other Intangible Assets – $773,000.00 – – –
-Accumulated Depreciation – – – -$1.50M -$1.50M
Long Term Debt and Capital Lease Obligation – – – $0.00 $0.00
-Long Term Capital Lease Obligation – – – $0.00 $0.00

Cash flow

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Operating Cash Flow -$81.74M -$77.54M -$86.15M -$249.07M -$76.33M
Net cash flow from continuing operations -$81.74M -$77.54M -$86.15M -$249.07M -$76.33M
Net Income from Continuing Operations -$94.23M -$83.72M -$92.56M -$303.27M -$88.91M
Depreciation & Depletion & Amortization $33,000.00 $33,000.00 $39,000.00 $140,000.00 $28,000.00
Other Non-Cash Items $327,000.00 $319,000.00 $197,000.00 $1.03M $264,000.00
Change in Working Capital -$1.93M -$4.79M -$10.28M $22.68M $3.03M
-Change in Prepaid Assets -$4.12M -$2.86M $672,000.00 $640,000.00 -$4.89M
-Change in Payables and Accrued Expense $3.91M -$943,000.00 -$10.86M $23.30M $8.23M
-Change in Other Current Liabilities -$355,000.00 -$348,000.00 -$101,000.00 -$1.26M -$326,000.00
-Change In Other Working Capital -$1.35M – – – –
Net cash flow from investing -$32.10M $10.98M -$344.28M -$311.15M -$328.39M
Net Cash Flow from Continuing Investing Activities -$32.10M $10.98M -$344.28M -$311.15M -$328.39M
Net PPE Purchase and Sale -$1.55M -$245,000.00 -$62,000.00 -$56,000.00 $0.00
Net Investment Purchase and Sale -$27.32M $12.00M -$344.21M -$311.09M -$328.39M
Financing Cash Flow $929,000.00 $4.57M $609.43M $702.17M $612.52M
Net Cash Flow from Continuing Financing Activities $929,000.00 $4.57M $609.43M $702.17M $612.52M
Net Common Stock Issuance $0.00 $0.00 $621.24M $690.99M $601.73M
Proceeds from Stock Option Exercised $1.42M $4.88M $1.12M $13.27M $11.61M
Net Other Financing Charges -$493,000.00 -$310,000.00 -$12.92M -$2.09M -$819,000.00
Ending Cash Balance $361.85M $474.76M $536.75M $357.75M $357.75M
Net Change in Cash -$112.91M -$61.99M $179.00M $141.96M $207.80M
Beginning Cash Balance $474.76M $536.75M $357.75M $215.79M $149.94M
Free Cash Flow -$82.52M -$78.56M -$86.21M -$249.12M -$76.33M

Discussion

No comments yet — be the first to weigh in on PRAX.

Sign in to join the discussion.

Scroll to Top